期刊文献+

系统性红斑狼疮患者外周血白细胞增多的临床观察

下载PDF
导出
摘要 目的:探讨系统性红斑狼疮患者外周血白细胞增多的临床意义。方法:采用回顾性分析的方法,分析我院收治的系统性红斑狼疮患者临床资料,依据白细胞增多和减少分为两组。结果:白细胞增多组稳定期发病率高于白细胞减少组,进展期低于白细胞减少组;白细胞增多组的发热、皮疹、关节肿痛、感染等临床症状的发生率均高于白细胞减少组;白细胞增多组血沉低于白细胞减少组,而CPR高于白细胞减少组,P<0.05,差异均有统计学意义。结论:系统性红斑狼疮患者外周血白细胞增多患者应结合临床症状和其它指标,有依据地指导临床用药。
作者 李少玉
出处 《亚太传统医药》 2010年第7期104-105,共2页 Asia-Pacific Traditional Medicine
  • 相关文献

参考文献3

二级参考文献19

  • 1郑朝晖,刘升云,高冠民,李红,刘章锁.血液系统异常的系统性红斑狼疮78例分析[J].郑州大学学报(医学版),2005,40(5):930-931. 被引量:3
  • 2池淑红,赵晓燕.系统性红斑狼疮血液系统损害100例临床分析[J].卫生职业教育,2005,23(24):103-104. 被引量:1
  • 3Abrahamovicz M,Fortin PR,Du-Berger R,et al.The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus:a decision aid for development of entry criteria for clinical trials[J].J Rheumatol,1998,25:277-284.
  • 4Hebert LA,Dillon JJ,Middendorf DF,et al.Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus[J].Am J Kidney,1995,26(3):432-438.
  • 5Nossent JC.SLICC/ACR damage index in Afro-Caribbean patients with systemic lupus erythematosus : changes in and relationship to disease activity,corticosteroid therapy,and prognosis[J].J Rheumatol,1998,25:277-284.
  • 6Unowitz MB,Gladman DD.The lupus activity criteria count[J].J Rheum,1984,11:783.
  • 7Roberti I, Dikman S, Spiera H,et al.Comparative value of urinalysis, urine cytology and urine sIL2R in the assessment of renal disease in patients with systemic lupus erythematosus (SLE)[J].Clin Nephrol,1996,46(3):176-182.
  • 8Gladman DD,Goldsmith C,Urowitz M,et al.Derivation of a weighting scale for the SLICC/ACR damage index:preliminary results[J].Arthritis Rheum,1994,37(S):S326.
  • 9Unanue ER, Allen PM. The basis for immtmoregulatory role of macrophages and other accessory cells[ J]. Science, 1987,236( 4801 ) : 551 - 557.
  • 10Pawelec G,Ziegler A,Wernet P. Dissection of human allostimulatory determinants with cloned T cells: stimulation inhibition by monoclonal antibodies TU22, 34, 35, 36, 37, 39, 43, and 58 against distinct human MHC class Ⅱ molecules [ J]. Human Immunol, 1985,12(3) :165 - 176.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部